Skip to main content
APURES CO., LTD. logo

APURES CO., LTD. — Investor Relations & Filings

Ticker · 149300 ISIN · KR7149300006 KO Professional, scientific and technical activities
Open in API
Filings indexed 196 across all filing types
Latest filing 2022-03-07 AGM Information
Country KR South Korea
Listing KO 149300

About APURES CO., LTD.

https://www.apures.com/

APURES CO., LTD. is a biotechnology company specializing in research and development solutions centered on its proprietary "MICROPIG" platform. This internationally registered minipig model, which is anatomically and physiologically similar to humans, serves as a foundation for the company's diverse offerings. APURES develops and supplies standard and transgenic MICROPIG models, along with a portfolio of derived bio-resources including organs, tissues, and standardized primary cells for cell-based assays. The company provides comprehensive non-clinical contract research organization (CRO) services, offering integrated in-vitro and in-vivo testing solutions tailored for new drug development. Additionally, APURES is advancing into therapeutic innovation, developing bio-materials for xenotransplantation and tissue engineering, and pursuing the development of its own pipeline of gene therapies.

Recent filings

Filing Released Lang Actions
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a short regulatory filing (673 characters) submitted to the Korea Exchange (KRX) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company cannot avoid the designated 'concentrated date' for its AGM. Since it is a regulatory notification regarding meeting logistics rather than the AGM presentation materials themselves, and it does not fit into specific categories like proxy solicitation or voting results, it is classified as a general regulatory filing.
2022-03-07 Korean
증권발행결과(자율공시)(제3자배정 유상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a third-party capital increase (share issuance) by the company Apures. It details the number of shares issued, the total amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2022-02-21 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from a Korean company, specifically detailing a 'Decision on Paid-in Capital Increase' (유상증자결정). This document outlines the issuance of new shares, the purpose of the capital raise, the pricing methodology, and the third-party allocation details. In the context of financial filings, announcements regarding capital structure changes, such as new share issuances or capital increases, are classified under 'Share Issue/Capital Change'.
2022-02-10 Korean
[기재정정]전환청구권행사(제8회차)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from a Korean company (Apures) regarding the exercise of conversion rights (전환청구권 행사) for convertible bonds (CB). It details the conversion of debt into equity, which results in the issuance of new shares. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'Share Issue/Capital Change' (SHA) category.
2021-12-23 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure period for an upcoming Annual General Meeting (AGM). It does not contain the full meeting materials or proxy statements, but rather serves as a formal regulatory notice of the procedural steps for the meeting. Given it is a standard regulatory disclosure regarding corporate governance and meeting preparation, it fits best under the RNS category.
2021-12-16 Korean
[기재정정]전환청구권행사(제8회차)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from a Korean company (Apures) regarding the exercise of conversion rights (전환청구권 행사) for convertible bonds (CB). It details the conversion of debt into equity, including the number of shares issued, the conversion price, and the listing date of the new shares. This type of filing, which involves changes to the company's capital structure through the conversion of debt instruments into shares, falls under the 'Share Issue/Capital Change' category.
2021-11-23 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.